Introduction {#Sec1}
============

The increasing antibiotic resistance pose serious concerns in health sector and necessitates seeking natural alternatives. The marine ecosystem being less explored, have prospects for finding novel bioactive producing microbes. Marine microbes represent a distinctive group of organism owing to their immense genetic (Strobel and Daisy [@CR27]) and biochemical diversity (Rusch et al. [@CR25]) and are rich sources of a large variety of bioactive compounds (Debbab et al. [@CR5]). These originate mainly in sediments but they are also present in open oceans in association with other marine organisms (Supriya and Yogesh [@CR28]). Marine invertebrates and plants, in particular, represent an environment rich in microorganisms that produce compounds with bioactive properties including antibacterial, antifungal, antiviral, anticancer, antifouling and antibiofilm activities (Glöckner et al. [@CR9]). The microbial symbionts were been crucial in the discovery of many bioactive compounds reported earlier. The competition among microbes for space and nutrients is one of the driving forces behind the production of precious antibiotics and other useful pharmaceuticals in the marine environment (Thakur et al. [@CR31]). Microorganisms associated with marine invertebrates are proved to be valuable candidates for drug discovery (Jensen and Fenical [@CR14]; Hentschel et al. [@CR10]; Imada [@CR11]; Thakur et al. [@CR30]).

The marine microbes include cellular life forms such as bacteria, fungi and plankton, along with viruses that free load along with them. The marine bacteria represent one of the hardly untapped sources of potent therapeutic and novel drug leads. The emergence of multidrug resistant bacteria poses a major threat which in turn forces the discovery of new potent drugs to replace the conventional antibiotics. The decline in the discovery of newer antibiotics of the terrestrial origin necessitates exploring new ecological niches most notably the marine. Marine bacteria showing antibacterial activities have been isolated from various biotypes and most frequently isolated strains belong to the genus *Bacillus, Micrococcus, Pseudomonas, Vibrio, Flavobacterium,* and *Alteromonas* (Jayanth et al. [@CR13]; Nithya et al. [@CR19]; Eltmany et al. [@CR7]; Marinho et al. [@CR17]; Baranova and Eqorov [@CR2]; Leon et al. [@CR16]). However, a major constraint in the discovery of novel drugs from the marine microbes rely up on the fact that majority of the marine microbes are uncultivable in the laboratory conditions. Nevertheless, using cultivated microorganisms is still the only way to get detailed information about microbial characteristics and processes, thus highlighting the need to further focus on culturing microorganisms and developing better culturing techniques (Glöckner et al. [@CR9]).

Marine microbes are rich and yet less harnessed source of structurally diverse secondary metabolites, many of which possess unique biological activities. The present study attempts to isolate and screen novel bioactive producing microbes from the Vizhinjam and Mullor area of the South-west coast of India, which are known for their rich biodiversity and novel compounds in them.

Materials and methods {#Sec2}
=====================

Collection of samples {#Sec3}
---------------------

The marine samples for the isolation of microorganisms were collected from the Vizhinjam and Mulloor coast of Kerala, India. The geographical position of Vizhinjam coast is Longitude E 76°59′ and Latitude N 8°22′.

The samples collected include the Sepia and Crab from the fish landing centre in Vizhinjam coast and Limpets, macroalgae and the sediments from the Mulloor coast. The samples except marine sediments soon after collection were washed with sterile distilled water to remove the soil and brought to the laboratory in sterile polythene bags.

Isolation of associated microbes from the marine samples {#Sec4}
--------------------------------------------------------

The samples viz., crab, sepia and limpets after removing their outer shell and intestine and the macroalgae were crushed. The resultant was serially diluted in normal saline (0.85 % NaCl) and 0.1 ml spread plated in Zobell Marine Agar (Hi-Media), glucose agar and starch-casein agar to determine the growth of bacteria, fungi and actinomycetes respectively. Similarly, the coastal sediments were serially diluted and plated. The plates were monitored for 48 h by incubating at 37 °C for distinct bacterial colonies. The plated glucose agar was incubated at 27 ± 2 °C for 48 h and starch-casein agar at 27 ± 2 °C for 5--7 days to examine the growth of marine fungi and actinomycetes respectively. In all the cases, CFU/ml was recorded and the morphologically distinct colonies of the bacteria, fungi and actinomycetes were streak plated in respective agar plates to get the auxenic microbial isolate. The pure cultures of the isolates were stored in glycerol stocks at refrigeration temperatures for further studies.

Screening of antibacterial activity of the isolated marine microbes {#Sec5}
-------------------------------------------------------------------

The indicator strains used to determine the antibacterial activity of the isolated marine bacteria, fungi and actinomycetes included both the human pathogenic and fish pathogenic bacteria and are listed in Table [1](#Tab1){ref-type="table"}. The bacterial cultures were stored in agar slants at refrigeration temperatures and were activated in fresh nutrient agar medium as and when required.Table 1Indicator bacterial strains used for screening the antibacterial activity of isolated Marine microorganismsSl. no.Bacterial strainsSource1*Klebsiella pneumoniae* KU1Clinical isolate2*Pseudomonas aeruginosa* VL3Clinical isolate3*Salmonella enterica typhimurium* MTCC 98MTCC^a^4*Escherichia coli* MTCC 40MTCC5*Micrococcus luteu*s MTCC 105MTCC6*Staphylococcus simulans* MTCC 3610MTCC7*Proteus vulgaris* MTCC 426MTCC8*Vibrio fluvalis*Fish pathogen9*Vibrio* sp. P3aMarine isolate10*Vibrio* sp. P3bMarine isolate^a^Microbial type culture collection

The isolated marine bacteria were inoculated on to 10 ml of Zobell Marine Broth and incubated under shaking conditions at 37 °C for 48 h. After the respective incubation period, 1 ml of sample was withdrawn from the culture flask and centrifuged at 10,000 rpm for 15 min. The pellet was discarded and the supernatant so obtained was filtered using 0.22 µm microfilter (Hi-Media). The resultant cell free supernatant was examined for antibacterial activity against the indicator bacterial strains. For determining the antibacterial activity of the fungal isolates and actinomycetes, the strains were inoculated in glucose broth and starch-casein broth and incubated for 5 and 7 days respectively under shaking conditions. The indicator strains were activated in Nutrient Broth (Hi-Media) by incubating the inoculated broth for 24 h at 37 °C. The antibacterial activity was detected using the well-diffusion method (BSI [@CR3]). The bacterial culture was swabbed on to Mueller--Hinton agar (Hi-Media) plates. Using a cork borer, wells of 7 mm diameter was made on the agar plates containing the lawn of indicator bacterial strain. The cell free supernatant (50 µl) of the marine microbes was added to each well and incubated for 24 h at 37 °C. The plates were observed for the zones of inhibition around the well and the zone diameter (mm) was recorded.

Determination of growth characteristics of the potent bacterial isolate {#Sec6}
-----------------------------------------------------------------------

Among the microbes screened for bioactive production, active marine bacterial isolate BCS4 was subjected to determination of growth characteristics for effective extraction of the bioactive compound. The bacterial isolate BCS4 was inoculated in 100 ml Zobell Marine Broth and growth and bioactivity was determined every 24 h interval for 120 h. The determination of growth was carried out by taking the optical density of the inoculated culture broth at 600 nm after every 24 h. The bioactivity was determined by assaying the cell-free supernatant against the indicator strains selected by well-diffusion method as described earlier.

Extraction and chemical screening of bioactive compound from the potent isolate {#Sec7}
-------------------------------------------------------------------------------

The potent isolate was inoculated into 100 ml of Zobell Marine Broth and incubated at 37 °C for 96 h. The culture was then centrifuged at 10,000 rpm for 15 min and the supernatant filtered. The resultant filtrate was extracted separately with solvents viz., methanol, ethyl acetate, benzene and hexane @ 1 ml/ml culture supernatant of the marine isolate and dried at room temperature (28 ± 2 °C); in order to determine the best solvent extraction strategy for this bioactive compound. The well-diffusion assay method was used to determine the bioactivity of the extracted compounds. The solvent which extracted the compound better was used for the further extraction of the bioactive compound.

Thin layer chromatography (TLC) technique was employed to screen the bioactive compound. The crude ethyl acetate extract obtained from *Bacillus* sp. BCS4 was partially purified by TLC using silica gel coated chromatography plates. In order to determine the best solvent system for effective separation of crude compound, solvents such as ethyl acetate, methanol, chloroform and water were used in the proportions viz., (1) Ethyl acetate:Methanol:Water (20:2.7:2; v/v/v), (2) Ethyl acetate:Methanol:Water (20:2.8:1; v/v/v) and (3) Chloroform:Methanol (9:1; v/v). An aliquot of crude extract was spotted onto the silica gel plate and allowed to dry for a few minutes. Afterwards, the plate was developed with the solvent as mobile phase in the earlier mentioned proportion in a previously saturated glass chamber with eluting solvents for 30 min at room temperature. The developed plate was dried under normal air and the spots were visualized under visible light. Retention factor (Rf) value of the spot separated on the TLC Plate was determined by adopting the formula,$$\documentclass[12pt]{minimal}
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                \begin{document}$${\text{Rf value}} = \frac{\text{Movement of solute from the origin}}{\text{Movement of the solvent from the origin}}$$\end{document}$$The TLC plates were observed for distinct bands. The compound was eluted from the developed plate by scrapping off silica gel and mixed well with ethyl acetate and centrifuged for 10 min at 10,000 rpm. The supernatant was subjected to determination of bioactivity using well-diffusion assay against the indicator strain *S. simulans* MTCC3610 and observed for inhibition zone after incubation at 37 °C for 24 h.

Molecular characterization of the strain BCS4 {#Sec8}
---------------------------------------------

The molecular characterization of the active marine bacterial isolate which showed maximum inhibitory activity against the indicator strains tested were subjected to biochemical and molecular characterization studies based on 16S ribosomal RNA sequencing. The total genomic DNA extraction of the active bacteria cultured in Zobell Marine Broth was carried out by Phenol/chloroform extraction method. The 16S rRNA gene of the isolate was amplified using Universal Eubacterial 16S rRNA gene primers and sequenced. The resultant 16S rRNA gene sequence from the potent isolate BCS4 was compared with other bacterial sequences from the GenBank nucleotide database with BLAST (Altschul et al. [@CR1]) to analyse pairwise homology and phylogenetically analyzed using MEGA 6.01 software.

Results {#Sec9}
=======

Isolation of microorganisms from the marine invertebrates, macroalgae and coastal sediments {#Sec10}
-------------------------------------------------------------------------------------------

The samples from the marine environment (Vizhinjam and Mulloor Coast) used for the isolation of marine bacteria, fungi and actinomycetes include the coastal sediments, marine invertebrates viz., crab, sepia and limpet and the marine macroalgae. The isolated microorganisms from the respective agar plates after spread plating and incubation for 24 h were streaked to get pure cultures of the same. The bacteria were grown in Zobell Marine Agar medium; the list and source of the isolated bacterial strains are presented in Table [1](#Tab1){ref-type="table"}. The total count of bacteria per ml of the sample viz., coastal sediments, crab, sepia, limpets and the marine macroalgae was 6.5 × 10^6^, 3.2 × 10^5^, 5.9 × 10^5^, 1.9 × 10^5^ and 2.8 × 10^4^ CFU respectively (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Marine microbes associated with samples collected off south-west Coast of India

The actinomycetes isolated from different samples in starch-casein agar plates after spread plating and incubation for 7 days were streaked onto fresh starch-casein agar plates for getting pure culture of the same. The isolated actinomycetes from different marine sources are given in Table [2](#Tab2){ref-type="table"}. The macroalgal isolate AMA2 produced a pigmented colony upon incubation which yielded a red coloured pigmentation in the starch casein agar plate as well in the culture broth up on 7 days incubation. The total count of actinomycetes per ml of the sample viz., coastal sediments, crab, sepia, limpets and the marine macroalgae was 5.5 × 10^2^, 0, 2.9 × 10^2^, 0 and 1.9 × 10^2^ CFU respectively (Fig. [1](#Fig1){ref-type="fig"}).Table 2The bacterial, fungal and actinomycetes strains isolated from marine samplesMarine sampleMicrobes isolatedBacteriaFungiActinomycetesCoastal sedimentsBCS1FCS1ACS1BCS2FCS2ACS2BCS3BCS4CrabBCB1FCB1--BCB2FCB2SepiaBSP1FSP1ASP1BSP2FSP2ASP2BSP3FSP3BSP4FSP4BSP5LimpetsBLM1FLM1--BLM2FLM2BLM3MacroalgaeBMA1FMA1AMA1BMA2FMA2AMA2BMA3BMA4BMA5BMA6BMA7BMA8BMA9

Screening of antibacterial activity of the isolated marine microorganisms {#Sec11}
-------------------------------------------------------------------------

Of the 23 bacteria isolated from different marine sources, only five (22 %) bacterial strains viz, BLM3, BSP2, BCS1, BCS4 and BMA6 showed inhibitory activity against at least one of the tested strains when detected by well-diffusion method. The results revealed that the isolate from coastal sediments (BCS4) exhibited a broad activity spectrum inhibiting both Gram positive (*M. luteus* and *S. simulans*) and Gram negative (*Proteus vulgaris* and two *Vibrio* sp. P3a and P3b) bacteria.

The spectrum of inhibitory activity was narrow for the four strains (BLM3, BSP2, BCS1 and BMA6) which inhibited either one of the indicator strains. The coastal sediment isolates BSP1 and BSP4 exhibited 100 % inhibition against the marine *Vibrio* sp. P3a with zone of inhibition of 25 and 31 mm respectively. None of the marine actinomycetes and fungal isolates showed inhibitory activity against the tested pathogens. Hence, the bacterial isolate BCS4 which showed the highest bioactivity was subjected to further molecular characterization and elution of antibacterial compound.

The isolated actinomycetes and fungi did not produce significant inhibition zones against the tested pathogens; however, the macroalgal isolated actinomycetes strain AMA1 produced reddish pigment in Starch Casein medium which remained stable till the stationary phase of growth (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Antibacterial activity of Marine bacterial isolates

Growth characteristics and bioactive compound production by the bacterial isolate BCS4 {#Sec12}
--------------------------------------------------------------------------------------

The determination of growth of the potent marine isolate *Bacillus* sp. BCS4 revealed that the growth initiated after about 8 h of incubation, entered into the exponential phase after 24 h. The bacterium showed a steady growth till the 96th h after which it ceased to grow and entered the stationary phase followed by the decline. The steady rise in the growth rate indicated that the production of the metabolites maximized around 48 to 72 h (Fig. [3](#Fig3){ref-type="fig"}). The growth was followed by the production of bioactive metabolite which maximized at the 72th h of incubation and remained stable till the 96th h and decreased thereafter.Fig. 3Growth characteristics andbioactive compound production of Marine bacterial isolate BCS4

Solvent extraction of the bioactive compound {#Sec13}
--------------------------------------------

Among the solvents tested for better extraction of the bioactive compound, ethyl acetate extract gave wide zone of inhibition (Table [3](#Tab3){ref-type="table"}) against the test strains indicating the superiority of ethyl acetate over other solvents in extracting the bioactive compound of BCS4 (Fig. [4](#Fig4){ref-type="fig"}).Table 3Activity based extraction of the bioactive compound from *Bacillus* sp. BCS4 using different solventsSolventsZone diameter (mm)*S. simulansP. vulgaris*Methanol + BCS417.8 ± 0.36.67 ± 0.6Benzene + BCS413.7 ± 0.66.8 ± 0.3Ethyl acetate + BCS427.0 ± 0.311.7 ± 6Hexane + BCS4----Methanol alone----Benzene alone----Ethyl acetate alone----Hexane alone----Well diameter = 5 mm; '--' indicates absence of inhibition zone Fig. 4Zone of antibacterial inhibition of ethyl extract of *Bacillus* sp. BCS4 against *S. simulans* MTCC3610. **a** Ethyl acetate extract, **b** compound eluted from silica gel plate

The partial purification and chemical screening of the bioactive compound from the crude ethyl acetate extract was carried out using Thin Layer Chromatography. Distinct band was detected irrespective of the solvent systems, which is indicative of the presence of a compound in the crude extract. The Rf value was measured as 0.60, 0.72 and 0.79 cm for the solvent systems 1, 2 and 3 respectively. The ethyl acetate extracted compound eluted from the silica gel plate gave a zone of inhibition of 27.2 ± 0.3 mm against *S. simulans* MTCC 3610 confirming the bioactive potential.

Molecular characterization of the active marine bacterial isolate {#Sec14}
-----------------------------------------------------------------

The bacterial strain BCS4 which inhibited majority of the tested pathogens was characterized using 16S rRNA gene sequencing and the obtained sequence (749 bp) was blasted using Megablast tool of GenBank (<http://www.ncbi.nlm.nih.gov>). The blast results revealed 98 % similarity with the *Bacillus* sp. alk3. The phylogenetic tree was constructed through Neighbour Joining Method using Mega 6.0 software (Fig. [5](#Fig5){ref-type="fig"}). The active marine isolate was characterized as *Bacillus* sp. and designated *Bacillus* sp. BCS4.Fig. 5Phylogenetic tree drawn in MEGA 6.0 software using Neighbour Joining Method

Discussion {#Sec15}
==========

The marine ecosystem is less harnessed in terms of developing alternative drugs to antibiotics. The rich diversity, along with extreme physical conditions makes marine environment an ideal source for proving novel drug leads. The coasts, Vizhinjam and Mulloor along the south-west coast of India harbour rich and biodiverse flora and fauna with millions of microorganisms associated with it. When compared to the terrestrial counterparts, these flora and fauna and the marine environment, in general possess novel drugs and other chemically diverse bioactives (Delong [@CR6]). Though the percentage of culturable microbes remains too little, these can provide insights into the characteristics and potency of microbes (Glöckner et al. [@CR9]) thriving in such extreme conditions.

The marine microbial biota is rich and diverse. The study on the diversity of microbes from coastal sediments and marine flora and fauna revealed that the percentage of bacteria isolated from the studied marine sources was comparatively higher than actinomycetes and fungi. While no actinomycetes were isolated from limpets and crab, at least two fungal strains were isolated from them. Similar observation was made by Tawiah et al. ([@CR29]) for the samples collected from Cape Coast Duakor Sea beach at Gulf of Guinea in which the frequency of bioactive producing bacteria was high compared to actinomycetes and fungi. The results from that study also revealed 27 % antibiotic producing microorganism out of 119 isolated recovered. These observations coincided with the observations of the present study which gave 22 % bioactive producing bacteria. On the contrary, high rate of isolation of antibiotic producers (70 %) was recorded by O'Brien et al. ([@CR20]) from the Amazon basin.

The highest number of active isolates was obtained from the coastal sediments collected from Vizhinjam coast. The increased number of active isolates in the sediments than from the marine flora and fauna studied might be attributed to fact that the area of sample collection being a Fish Landing area and prone to pollution with fish wastes and other waste discharges, the microbes there might have accustomed to thrive by producing defense compounds. The findings are supported by the observations of Tawiah et al. ([@CR29]). The study also revealed active compound producing bacteria and the absence of inhibitory potential by isolated Actinomycetes and Fungi. The absence of the zone of inhibition by the fungal and actinomycetes strains against the tested pathogens might be attributed to the changes in culture conditions or the limitations in the strains tested etc. Further, the actinomycetes and fungi require condition optimization for the production of the bioactive compounds. This would require the standardization of the culture conditions or supplementation with different media components to enrich the medium to enable the production of such compounds. The study carried out Kiranmayi et al. ([@CR15]) employed 11 different culture media in order to determine the best production media for the isolated actinomycetes. The variations noted in the antibiotic producers among the isolated strains may also be due to it's dependence on the isolation and assay procedure, test organisms, type of media used and the sources of bacterial isolates (Giudice et al. [@CR8]). A salient finding noted from the present study that the actinomycete strain AMA1 produced a reddish pigment in Starch-Casein medium which remained stable till the stationary phase of growth. Earlier reports evidenced the production of antitumour (Soliev et al. [@CR26]; Olano et al. [@CR21]), antibacterial (Pham et al. [@CR22]) and other commercially important pigments from marine Actinomycetes. Studies also revealed prognosin like pigment production by Actinomycetes of marine origin (Quadri and Asgar [@CR23]; Chaudhary et al. [@CR4]). The studies on production and determination of the nature of the pigment produced by the strain AMA1 are needed further for characterization and evaluating it's applicational potentiality.

The bacterial isolate from coastal sediments (BCS4) exhibited a broad activity spectrum inhibiting both Gram positive (*Micrococcus luteus* and *Staphylococcus simulans*) and Gram negative (*Proteus vulgaris* and two *Vibrio* sp. P3a and P3b) bacteria. Similar broad activity spectrum was observed with marine *Pseudoalteromonas* species as was observed by Isnansetyo and Kamei ([@CR12]). The activity spectrum observed with the marine isolate in the study provides prospects for a future drug or bioactive lead. The growth pattern of the bacterial isolate revealed that the active metabolite production maximized at the late logarithmic phase (i.e., at the 72th h of incubation) and remained stable till the 96th h. Similar to this observation, Radhakrishna et al. ([@CR24]) noted maximum active metabolite production of sponge isolated *Bacillus subtilis* MTCC 10619 at the 72th h, which decreased thereafter.

The isolate with potent activity was phylogenetically confirmed as *Bacillus* sp. BCS4. It is evidenced from the reports of Mondol et al. ([@CR18]) that marine Bacillus isolates produce diverse bioactive metabolites with novel modes of action and has potentials for the development of effective management strategies to combat human, animal and phytopathogens in biorational manners. The activity spectrum noted for *Bacillus* sp. BCS4 is indicative of their possible medical and pharmaceutical applications. The compound was effectively extracted using the ethyl acetate solvent and the confirmation of the active compound in TLC provides insights into development of potent drugs out of this compound. Further work to detect the compound chemistry and the purification of the compound to homogeneity is under progress.
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